Discover Your Poo-tential and Become a Donor
“It’s convenient and easy place to go nearby to earn a side income. It’s a really easy process, and it helps people out in our community and others.”
“I have several friends who have gut issues. I feel for them, and I’m blessed with a healthy gut, so getting to help people like them through donating means a lot to me.”
“Something like this program can give you a sense of purpose. Donating something of yours that will benefit someone else, that’s important. It’s inspired me to pay more attention to what goes into my mouth, into my gut, and through my body. I don’t want to fill myself with junk anymore, because that will make for a healthier stool in the end.”
“I keep coming back because it’s directly helping people with C-diff. It’s literally saving lives, so that’s an improvement in this world.”
“When I learned about the program, I was intrigued by the opportunity to help people suffering from C. diff infections. I watched a loved one suffer terribly with C. diff, so I wanted to make a difference for others. I also liked the idea of earning extra income to pad my savings and to have “fun money” for things I enjoy, like travel and dining out.”
“I work in research in a different capacity, so I know the impact research studies can have and how they impact patients on the other side. I volunteer because I know that is what my donations go to, and the side benefit is getting reimbursed for my contributions. Hopefully it is making a difference in peoples’ lives.”
“Rebiotix was built upon a foundation of putting the patient at the forefront of everything that we do. You can find that passion in every corner of this company, and it is truly inspiring. That is what makes me so proud to be a part of this team.”
“First and foremost, in our mind is patient-centricity. “We’re really focused on keeping that front of mind in everything we do.”
Harnessing Impact through Stool Donations
C.diff infections in the U.S. every year1
C.diff recurrence rate1,2
Years of microbiome therapeutics development
Stool donations received
References:
1. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
2. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012;55(suppl 2):S154-S161.